IQVIA Holdings Inc.
NYSE:IQVMedical - Diagnostics & Research
-$3.13 today
- Market cap
- $42.49B
- Beta
- 1.22
- P/E (TTM)
- 20.4
- EPS (TTM)
- $8.22
Volume 1.40M
Average 1.62M
IQV Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
IQVIA Holdings Inc.NYSE: IQV
Accounts Payables · Q2 FY2026 · quarter ended Jun 2026
Accounts payables outflow grows to $0
Q2 FY2026 accounts payables was $0, compared with $0 a year earlier. Trailing-twelve-month accounts payables was $0.
Context
- Accounts payables amounted to 0.6% of revenue in FY2025, down 0.2 pp from a year earlier.
- Accounts payables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts payables holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- (96M) USD
- Year-over-year change
- -183.5%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (96M) | -183.5% |
| FY2024 | 2024-12-31 | 115M | -56.9% |
| FY2023 | 2023-12-31 | 267M | -37.5% |
| FY2022 | 2022-12-31 | 427M | +75.0% |
| FY2021 | 2021-12-31 | 244M | — |
Accounts Payables vs competitors
How IQV compares with its peers on the latest reported figures
- IQV's LTM Jun 2026 accounts payables of $0 is the 8th largest of the 9 companies compared; the peer median is $2.43M.
- Accounts payables amounts to 0.0% of revenue for IQV, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
FTREFortrea Holdings Inc. | LTM Jun 2026 | $38.5M | -26.8% | — | 1.4% |
| LTM Sep 2026 | $11.29M | +164.1% | -2.9% | 0.7% | |
| LTM Mar 2026 | $10.67M | +138.4% | — | 2.5% | |
| LTM Jun 2026 | $7.9M | -6.0% | — | 0.2% | |
| LTM Sep 2026 | $2.8M | +106.0% | -25.8% | 0.1% | |
| LTM Jul 2026 | $2.07M | -56.4% | -34.3% | 0.1% | |
| LTM Mar 2026 | $91K | -97.7% | +34.8% | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding IQV) | $2.43M | -6.0% | -14.4% | 0.1% | |
Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 966M | 1.09B | 1.36B | 1.37B | 1.36B |
| Depreciation & Amortization | 1.26B | 1.13B | 1.13B | 1.11B | 1.14B |
| Deferred Income Tax | (138M) | (115M) | (269M) | (129M) | (180M) |
| Stock-Based Compensation | 170M | 194M | 217M | 206M | 247M |
| Change in Working Capital | 680M | (84M) | (280M) | 158M | 125M |
| Accounts Receivables | (138M) | (421M) | (388M) | 182M | 60M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 244M | 427M | 267M | 115M | (96M) |
| Other Working Capital | 574M | (90M) | (159M) | (139M) | 161M |
| Other Non-Cash Items | 0 | 44M | (2M) | (6M) | (43M) |
| Operating Cash Flow | 2.94B | 2.26B | 2.15B | 2.72B | 2.65B |
| Capital Expenditures | (640M) | (674M) | (649M) | (602M) | (603M) |
| Acquisitions (Net) | (1.46B) | (1.34B) | (876M) | (710M) | (1.76B) |
| Purchases of Investments | (15M) | (5M) | (83M) | (134M) | (20M) |
| Sales of Investments | 5M | 0 | 0 | 0 | 2M |
| Other Investing Activities | 5M | 8M | 5M | 2M | 74M |
| Investing Cash Flow | (2.1B) | (2.01B) | (1.6B) | (1.44B) | (2.31B) |
| Debt Repayment | 70M | 941M | 802M | 553M | 1.21B |
| Common Stock Issued | 0 | 0 | 0 | 0 | (67M) |
| Common Stock Repurchased | (406M) | (1.17B) | (992M) | (1.35B) | (1.24B) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (899M) | (102M) | (192M) | (81M) | (44M) |
| Financing Cash Flow | (1.24B) | (329M) | (382M) | (878M) | (150M) |
| Effect of Forex Changes | (52M) | (75M) | (4M) | (68M) | 79M |
| Net Change in Cash | (448M) | (150M) | 160M | 326M | 278M |
| Free Cash Flow | 2.3B | 1.59B | 1.5B | 2.11B | 2.05B |
IQVIA Holdings Inc.
NYSE:IQV
Intrinsic Alpha fair value
Locked
Current Price
$257.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.